Clinical Trial Update: The Gut, Liver And Metabolome in Human Immunodeficiency Virus and Non Alcoholic Fatty Liver Disease [EARLY_Phase 1]

View source ↗

Summary

Phase 1 study updated on the gut, liver, and metabolome in people with HIV and fatty liver disease; the trial is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection
• Metabolic Dysfunction-associated Fatty Liver Disease
• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Vanderbilt University Medical Center | Conditions: HIV, Non-Alcoholic Fatty Liver Disease | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING